Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Illumina Stock a Buy?

TheMotleyFool

0 0

DNA sequencing giant Illumina (NASDAQ: ILMN) started 2020 off with what many might consider disappointing news, announcing that it had dropped the planned acquisition of Pacific Biosciences (NASDAQ: PACB). That followed a lackluster year for Illumina's shares, which took a 19% hit in July as the company reported lower-than-expected revenue in the second quarter.

But recent news should give investors reason to take a look at Illumina shares. The company reported fourth-quarter earnings that topped estimates, announced a collaboration agreement with Roche (OTC: RHHBY), and launched two new sequencing systems.

Image source: Getty Images.

Source Fool.com

Like: 0

ILMN

Share